
We Develop Pan Coronavirus Antivirals
HALO'S PROPRIETARY FREE FATTY ACID FORMULA IS A PAN CORONAVIRUS ANTIVIRAL
The pocket and antiviral mechanism we discovered are fully conserved in:
- SARS1 (2003), MERS (2012) and SARS-CoV-2 (2019)
- all Variants of Concern (VOC) alpha, beta, delta, omicron

OUR PIPELINE & SCIENCE
INVESTMENT, LICENSING, AND PARTNERING
Please contact us for partnering, licensing, or investment opportunities in pan coronavirus antivirals and potential antiviral drugs for Covid-19.
Our Company
Halo Executive Team

Prof. Adam Finn
- Head clinician in UK wide RECOVERY trial ongoing for COVID-19
- Designing our Clinical Trials
- Expert in viral transmission New York Times Article by Adam
NEWS

Experts fear condition will hit people’s ability to work and have costs for employers and government, Jane Dalton writes

The U.S. Food and Drug Administration is continually monitoring how authorized and approved treatments for COVID-19 are affected by changing variants

A resurgence of Covid cases is under way across the UK, with infections in the over-70s at a record high and school leaders fearing that preparations

The latest coronavirus news updated every day including coronavirus cases, the latest news, features and interviews
KEY PUBLICATIONS
Oskar Staufer, Kapil Gupta, Jochen Estebano Hernandez Bücher, Fabian Kohler, Christian Sigl, Gunjita Singh, Kate Vasileiou, Ana Yagüe Relimpio, Meline Macher, Sebastian Fabritz, Hendrik Dietz, Elisabetta Ada Cavalcanti Adam, Christiane Schaffitzel, Alessia Ruggieri, Ilia Platzman, Imre Berger & Joachim P. Spatz
Imre Berger, Christiane Schaffitzel
Contact Us
Halo Therapeutics
- Unit Dx, 1st Floor Room 101, St. Philips Central Albert Road, St. Philips, Bristol, England, BS2 0XJ
- +44 117 403 4035
- contact@halo-therapeutics.com